Contribution of neovascularization and intraplaque haemorrhage to atherosclerotic plaque progression and instability

Acta Physiologica

Volumn 213, Issue 3, 2015, Pages 539-553

  Chistiakov, D A ^a,b,c   Orekhov, A N ^d,e   Bobryshev, Y V ^d,f,g  

^a PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^b Mount Sinai Comprehensive Cancer Center   (United States)

^c Scientific Center of Children's Health   (Russian Federation)

^d INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

^e Institute for Atherosclerosis Research   (Russian Federation)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

Arterial wall; Atherogenesis; Atherosclerosis; Atherosclerotic plaque; Inflammation; Neovascularization

Indexed keywords

CHOLESTEROL ESTER; COLLAGEN; FIBRIN; HEME; HEMOGLOBIN; IRON; PROTEINASE; AUTACOID; CHOLESTEROL; PEPTIDE HYDROLASE;

ACUTE CORONARY SYNDROME; ADVENTITIA; ANGIOGENESIS; ATHEROSCLEROTIC PLAQUE; CELL GROWTH; CELL INFILTRATION; CEREBROVASCULAR ACCIDENT; CHRONIC INFLAMMATION; DISEASE COURSE; ERYTHROCYTE; HUMAN; INFLAMMATORY CELL; INTRAPLAQUE HEMORRHAGE; LIPID OXIDATION; MACROPHAGE; MAST CELL; MONOCYTE; NEOVASCULARIZATION (PATHOLOGY); NEUTROPHIL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SMOOTH MUSCLE FIBER; THROMBOSIS; VASA VASORUM; ANIMAL; ATHEROSCLEROSIS; BLOOD VESSEL; COMPLICATION; HEMORRHAGE; IMMUNOLOGY; METABOLISM; PATHOLOGY; RISK FACTOR; RUPTURE; SIGNAL TRANSDUCTION;

ANIMALS; ATHEROSCLEROSIS; BLOOD VESSELS; CHOLESTEROL; DISEASE PROGRESSION; HEMOGLOBINS; HEMORRHAGE; HUMANS; INFLAMMATION MEDIATORS; IRON; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE HYDROLASES; PLAQUE, ATHEROSCLEROTIC; RISK FACTORS; RUPTURE, SPONTANEOUS; SIGNAL TRANSDUCTION;

EID: 84921599835     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12438     Document Type: Review

References (169)

1. Abbate, A., Kontos, M.C., Grizzard, J.D., Biondi-Zoccai, G.G., Van Tassell, B.W., Robati, R., Roach, L.M., Arena, R.A., Roberts, C.S., Varma, A., Gelwix, C.C., Salloum, F.N., Hastillo, A., Dinarello, C.A. & Vetrovec, G.W.; VCU-ART Investigators 2010. Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study). Am J Cardiol 105, 1371-1377.e1.
2. Abbate, A., Van Tassell, B.W., Biondi-Zoccai, G., Kontos, M.C., Grizzard, J.D., Spillman, D.W., Oddi, C., Roberts, C.S., Melchior, R.D., Mueller, G.H. et al. 2013. Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) pilot study]. Am J Cardiol 111, 1394-1400.
3. Abela, G.S. & Aziz, K. 2006. Cholesterol crystals rupture biological membranes and human plaques during acute cardiovascular events-a novel insight into plaque rupture by scanning electron microscopy. Scanning 28, 1-10.
4. Abela, G.S., Aziz, K., Vedre, A., Pathak, D.R., Talbott, J.D. & Dejong, J. 2009. Effect of cholesterol crystals on plaques and intima in arteries of patients with acute coronary and cerebrovascular syndromes. Am J Cardiol 103, 959-968.
5. Abela, G.S., Vedre, A., Janoudi, A., Huang, R., Durga, S. & Tamhane, U. 2011. Effect of statins on cholesterol crystallization and atherosclerotic plaque stabilization. Am J Cardiol 107, 1710-1717.
6. Abraham, N.G., Lavrovsky, Y., Schwartzman, M.L., Stoltz, R.A., Levere, R.D., Gerritsen, M.E., Shibahara, S. & Kappas, A. 1995. Transfection of the human heme oxygenase gene into rabbit coronary microvessel endothelial cells: protective effect against heme and hemoglobin toxicity. Proc Natl Acad Sci USA 92, 6798-6802.
7. Aikawa, M., Rabkin, E., Sugiyama, S., Voglic, S.J., Fukumoto, Y., Furukawa, Y., Shiomi, M., Schoen, F.J. & Libby, P. 2001. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation 103, 276-283.
8. Alam, J. & Smith, A. 1992. Heme-hemopexin-mediated induction of metallothionein gene expression. J Biol Chem 267, 16379-16384.
9. Ammirati, E., Vermi, A.C., Cianflone, D., Banfi, M., Foglieni, C., Godino, C., Airoldi, F., Ferri, L.A., Gorman, C.L., Manfredi, A.A., Maseri, A., Cope, A.P. & Monaco, C. 2008. Expansion of T-cell receptor zeta dim effector T cells in acute coronary syndromes. Arterioscler Thromb Vasc Biol 28, 2305-2311.
10. Andrews, S.C., Arosio, P., Bottke, W., Briat, J.F., von Darl, M., Harrison, P.M., Laulhère, J.P., Levi, S., Lobreaux, S. & Yewdall, S.J. 1992. Structure, function, and evolution of ferritins. J Inorg Biochem 47, 161-174.
11. Aronow, H.D., Topol, E.J., Roe, M.T., Houghtaling, P.L., Wolski, K.E., Lincoff, A.M., Harrington, R.A., Califf, R.M., Ohman, E.M., Kleiman, N.S., Keltai, M., Wilcox, R.G., Vahanian, A., Armstrong, P.W. & Lauer, M.S. 2001. Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study. Lancet 357, 1063-1068.
12. Aubry, M.C., Riehle, D.L., Edwards, W.D., Maradit-Kremers, H., Roger, V.L., Sebo, T.J. & Gabriel, S.E. 2004. B-Lymphocytes in plaque and adventitia of coronary arteries in two patients with rheumatoid arthritis and coronary atherosclerosis: preliminary observations. Cardiovasc Pathol 13, 233-236.
13. Balla, G., Jacob, H.S., Eaton, J.W., Belcher, J.D. & Vercellotti, G.M. 1991. Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler Thromb 11, 1700-1711.
14. Balla, J., Vercellotti, G.M., Jeney, V., Yachie, A., Varga, Z., Eaton, J.W. & Balla, G. 2005. Heme, heme oxygenase and ferritin in vascular endothelial cell injury. Mol Nutr Food Res 49, 1030-1043.
15. Balla, J., Vercellotti, G.M., Jeney, V., Yachie, A., Varga, Z., Jacob, H.S., Eaton, J.W. & Balla, G. 2007. Heme, heme oxygenase, and ferritin: how the vascular endothelium survives (and dies) in an iron-rich environment. Antioxid Redox Signal 9, 2119-2137.
16. Barra, J.A., Bezon, E., Mondine, P., Resk, A., Gilard, M., Mansourati, J. & Boshat, J. 2000. Surgical angioplasty with exclusion of atheromatous plaques in case of diffuse disease of the left anterior descending artery: 2 years' follow-up. Eur J Cardiothorac Surg 17, 509-514.
17. Bavry, A.A., Mood, G.R., Kumbhani, D.J., Borek, P.P., Askari, A.T. & Bhatt, D.L. 2007. Long-term benefit of statin therapy initiated during hospitalization for an acute coronary syndrome: a systematic review of randomized trials. Am J Cardiovasc Drugs 7, 135-141.
18. van den Berg, J.J., Op den Kamp, J.A., Lubin, B.H., Roelofsen, B. & Kuypers, F.A. 1992. Kinetics and site specificity of hydroperoxide-induced oxidative damage in red blood cells. Free Radic Biol Med, 12, 487-498.
19. Bjornheden, T., Levin, M., Evaldsson, M. & Wiklund, O. 1999. Evidence of hypoxic areas within the arterial wall in vivo. Arterioscler Thromb Vasc Biol 19, 870-876.
20. Bobryshev, Y.V., Cherian, S.M., Inder, S.J. & Lord, R.S. 1999. Neovascular expression of VE-cadherin in human atherosclerotic arteries and its relation to intimal inflammation. Cardiovasc Res 43, 1003-1017.
21. Bona, R.D., Liuzzo, G., Pedicino, D. & Crea, F. 2011. Anti-inflammatory treatment of acute coronary syndromes. Curr Pharm Des 17, 4172-4189.
22. Boodhwani, M., Nakai, Y., Voisine, P., Feng, J., Li, J., Mieno, S., Ramlawi, B., Bianchi, C., Laham, R. & Sellke, F.W. 2006. High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response. Circulation 114(1 Suppl), I402-I408.
23. Boyle, J.J. 2012. Heme and haemoglobin direct macrophage Mhem phenotype and counter foam cell formation in areas of intraplaque haemorrhage. Curr Opin Lipidol 23, 453-461.
24. Boyle, J.J., Harrington, H.A., Piper, E., Elderfield, K., Stark, J., Landis, R.C. & Haskard, D.O. 2009. Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype. Am J Pathol 174, 1097-1108.
25. Brinckerhoff, C.E. & Matrisian, L.M. 2002. Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 3, 207-214.
26. Brown, A.J., Mander, E.L., Gelissen, I.C., Kritharides, L., Dean, R.T. & Jessup, W. 2000. Cholesterol and oxysterol metabolism and subcellular distribution in macrophage foam cells. Accumulation of oxidized esters in lysosomes. J Lipid Res 41, 226-237.
27. Chade, A.R., Bentley, M.D., Zhu, X., Rodriguez-Porcel, M., Niemeyer, S., Amores-Arriaga, B., Napoli, C., Ritman, E.L., Lerman, A. & Lerman, L.O. 2004. Antioxidant intervention prevents renal neovascularization in hypercholesterolemic pigs. J Am Soc Nephrol 15, 1816-1825.
28. Chen, H.X. & Cleck, J.N. 2009. Adverse effects of anticancer agents that target the VEGF pathway. Nat Rev Clin Oncol 6:465-477.
29. Chen, J.X. & Stinnett, A. 2008. Disruption of Ang-1/Tie-2 signaling contributes to the impaired myocardial vascular maturation and angiogenesis in type II diabetic mice. Arterioscler Thromb Vasc Biol 28, 1606-1613.
30. Chen, J.X., Zeng, H., Reese, J., Aschner, J.L. & Meyrick, B. 2012. Overexpression of angiopoietin-2 impairs myocardial angiogenesis and exacerbates cardiac fibrosis in the diabetic db/db mouse model. Am J Physiol Heart Circ Physiol 302, H1003-H1012.
31. Cheng, X., Yu, X., Ding, Y.J., Fu, Q.Q., Xie, J.J., Tang, T.T., Yao, R., Chen, Y. & Liao, Y.H. 2008. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 127, 89-97.
32. Chistiakov, D.A., Sobenin, I.A. & Orekhov, A.N. 2013. Vascular extracellular matrix in atherosclerosis. Cardiol Rev 21, 270-288.
33. Cimmino, G., Ragni, M., Cirillo, P., Petrillo, G., Loffredo, F., Chiariello, M., Gresele, P., Falcinelli, E. & Golino, P. 2013. C-reactive protein induces expression of matrix metalloproteinase-9: a possible link between inflammation and plaque rupture. Int J Cardiol, 168, 981-986.
34. Crea, F. & Liuzzo, G. 2013. Pathogenesis of acute coronary syndromes. J Am Coll Cardiol 61, 1-11.
35. de la Cuesta, F., Alvarez-Llamas, G., Maroto, A.S., Donado, A., Zubiri, I., Posada, M., Padial, L.R., Pinto, A.G., Barderas, M.G. & Vivanco, F. 2011. A proteomic focus on the alterations occurring at the human atherosclerotic coronary intima. Mol Cell Proteomics 10, M110.003517.
36. Czepluch, F.S. & Waltenberger, J. 2007. High-dose atorvastatin is associated with impaired myocardial angiogenesis in response to vascular endothelial growth factor in hypercholesterolemic swine: relevance to the human situation? J Thorac Cardiovasc Surg 133, 1685-1686.
37. Dale, D.C., Boxer, L. & Liles, W.C. 2008. The phagocytes: neutrophils and monocytes. Blood 112, 935-945.
38. De Palma, R., Del Galdo, F., Abbate, G., Chiariello, M., Calabró, R., Forte, L., Cimmino, G., Papa, M.F., Russo, M.G., Ambrosio, G. et al. 2006. Patients with acute coronary syndrome show oligoclonal T-cell recruitment within unstable plaque: evidence for a local, intracoronary immunologic mechanism. Circulation 113, 640-646.
39. Di Stefano, R., Felice, F. & Balbarini, A. 2009. Angiogenesis as risk factor for plaque vulnerability. Curr Pharm Des 15, 1095-1106.
40. Doronzo, G., Russo, I., Mattiello, L., Trovati, M. & Anfossi, G. 2005. C-reactive protein increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells. J Lab Clin Med 146, 287-298.
41. Dorweiler, B., Torzewski, M., Dahm, M., Kirkpatrick, C.J., Lackner, K.J. & Vahl, C.F. 2008. Subendothelial infiltration of neutrophil granulocytes and liberation of matrix-destabilizing enzymes in an experimental model of human neo-intima. Thromb Haemost 99, 373-381.
42. Duewell, P., Kono, H., Rayner, K.J., Sirois, C.M., Vladimer, G., Bauernfeind, F.G., Abela, G.S., Franchi, L., Nuñez, G., Schnurr, M. et al. 2010. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357-1361.
43. null T cells in coronary artery disease: when helpers become killers. Cardiovasc Res 81, 11-19.
44. null T cells in patients with acute coronary syndrome. Circ Res 110, 857-869.
45. Dunmore, B.J., McCarthy, M.J., Naylor, A.R. & Brindle, N.P. 2007. Carotid plaque instability and ischemic symptoms are linked to immaturity of microvessels within plaques. J Vasc Surg 45, 155-159.
46. Falke, P., Mätzsch, T., Sternby, N.H., Bergqvist, D. & Stavenow, L. 1995. Intraplaque haemorrhage at carotid artery surgery-a predictor of cardiovascular mortality. J Intern Med 238, 131-135.
47. Farbstein, D. & Levy, A.P. 2010. The genetics of vascular complications in diabetes mellitus. Cardiol Clin 28, 477-496.
48. Finn, A.V., Nakano, M., Narula, J., Kolodgie, F.D. & Virmani, R. 2010. Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 30, 1282-1292.
49. Finn, A.V., Nakano, M., Polavarapu, R., Karmali, V., Saeed, O., Zhao, X., Yazdani, S., Otsuka, F., Davis, T., Habib, A., Narula, J., Kolodgie, F.D. & Virmani, R. 2012. Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques. J Am Coll Cardiol 59, 166-177.
50. Fleiner, M., Kummer, M., Mirlacher, M., Sauter, G., Cathomas, G., Krapf, R. & Biedermann, B.C. 2004. Arterial neovascularization and inflammation in vulnerable patients: early and late signs of symptomatic atherosclerosis. Circulation 110, 2843-2850.
51. Gadeela, N., Rubinstein, J., Tamhane, U., Huang, R., Pathak, D.R., Hosein, H.A., Rich, M., Dhar, G. & Abela, G.S. 2011. The impact of circulating cholesterol crystals on vasomotor function: implications for no-reflow phenomenon. JACC Cardiovasc Interv 4, 521-529.
52. Galis, Z.S., Muszynski, M., Sukhova, G.K., Simon-Morrissey, E., Unemori, E.N., Lark, M.W., Amento, E. & Libby, P. 1994a. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 75, 181-189.
53. Galis, Z.S., Sukhova, G.K., Lark, M.W. & Libby, P. 1994b. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94, 2493-2503.
54. Galis, Z.S., Sukhova, G.K., Kranzhofer, R., Clark, S. & Libby, P. 1995. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci USA 92, 402-406.
55. Gessi, S., Fogli, E., Sacchetto, V., Merighi, S., Varani, K., Preti, D., Leung, E., Maclennan, S. & Borea, P.A. 2010. Adenosine modulates HIF-1alpha, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells. Arterioscler Thromb Vasc Biol 30, 90-97.
56. Gössl, M., Versari, D., Mannheim, D., Ritman, E.L., Lerman, L.O. & Lerman, A. 2007. Increased spatial vasa vasorum density in the proximal lad in hypercholesterolemia-implications for vulnerable plaque-development. Atherosclerosis 192, 246-252.
57. Gössl, M., Herrmann, J., Tang, H., Versari, D., Galili, O., Mannheim, D., Rajkumar, S.V., Lerman, L.O. & Lerman, A. 2009a. Prevention of vasa vasorum neovascularization attenuates early neointima formation in experimental hypercholesterolemia. Basic Res Cardiol 104, 695-706.
58. Gössl, M., Versari, D., Lerman, L.O., Chade, A.R., Beighley, P.E., Erbel, R. & Ritman, E.L. 2009b. Low vasa vasorum densities correlate with inflammation and subintimal thickening: potential role in location-Determination of atherogenesis. Atherosclerosis 206, 362-368.
59. Gough, P.J., Gomez, I.G., Wille, P.T. & Raines, E.W. 2006. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J Clin Invest 116, 59-69.
60. Hakimi, M., Hyhlik-Dürr, A., von Au, A., Betz, M., Demirel, S., Dihlmann, S., Böckler, D. & Gross-Weissmann, M.L. 2013. The expression of glycophorin A and osteoprotegerin is locally increased in carotid atherosclerotic lesions of symptomatic compared to asymptomatic patients. Int J Mol Med 32, 331-338.
61. Hellings, W.E., Peeters, W., Moll, F.L., Piers, S.R., van Setten, J., Van der Spek, P.J., de Vries, J.P., Seldenrijk, K.A., De Bruin, P.C., Vink, A., Velema, E., de Kleijn, D.P. & Pasterkamp, G. 2010. Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: a prognostic study. Circulation 121, 1941-1950.
62. Herrmann, J., Lerman, L.O., Rodriguez-Porcel, M., Holmes, D.R., Richardson, D.M., Ritman, E.L. & Lerman, A. 2001. Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. Cardiovasc Res 51, 762-766.
63. Hosokawa, T., Kumon, Y., Kobayashi, T., Enzan, H., Nishioka, Y., Yuri, K., Wakiguchi, H. & Sugiura, T. 2011. Neutrophil infiltration and oxidant-production in human atherosclerotic carotid plaques. Histol Histopathol 26, 1-11.
64. Hutter, R., Speidl, W.S., Valdiviezo, C., Sauter, B., Corti, R., Fuster, V. & Badimon, J.J. 2013. Macrophages transmit potent proangiogenic effects of oxLDL in vitro and in vivo involving HIF-1α activation: a novel aspect of angiogenesis in atherosclerosis. J Cardiovasc Transl Res 6, 558-569.
65. Ionita, M.G., van den Borne, P., Catanzariti, L.M., Moll, F.L., de Vries, J.P., Pasterkamp, G., Vink, A. & de Kleijn, D.P. 2010. High neutrophil numbers in human carotid atherosclerotic plaques are associated with characteristics of rupture-prone lesions. Arterioscler Thromb Vasc Biol 30, 1842-1848.
66. Iqbal, J., Gunn, J. & Serruys, P.W. 2013. Coronary stents: historical development, current status and future directions. Br Med Bull 106, 193-211.
67. Jesus, A.A. & Goldbach-Mansky, R. 2014. IL-1 blockade in autoinflammatory syndromes. Annu Rev Med 65, 223-244.
68. Johnson, J.L. 2007. Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability. Expert Rev Cardiovasc Ther 5, 265-282.
69. Jozkowicz, A., Dulak, J., Piatkowska, E., Placha, W. & Dembinska-Kiec, A. 2000. Ligands of peroxisome proliferator-activated receptor-gamma increase the generation of vascular endothelial growth factor in vascular smooth muscle cells and in macrophages. Acta Biochim Pol 47, 1147-1157.
70. ten Kate, G.L., Sijbrands, E.J., Valkema, R., ten Cate, F.J., Feinstein, S.B., van der Steen, A.F., Daemen, M.J. & Schinkel, A.F. 2010. Molecular imaging of inflammation and intraplaque vasa vasorum: a step forward to identification of vulnerable plaques? J Nucl Cardiol 17, 897-912.
71. Ketelhuth, D.F. & Bäck, M. 2011. The role of matrix metalloproteinases in atherothrombosis. Curr Atheroscler Rep 13, 162-169.
72. Khatchadourian, Z.D., Moreno-Hay, I. & de Leeuw, R. 2014. Nonsteroidal anti-inflammatory drugs and antihypertensives: how do they relate? Oral Surg Oral Med Oral Pathol Oral Radiol 117, 697-703.
73. Kockx, M.M., Cromheeke, K.M., Knaapen, M.W., Bosmans, J.M., De Meyer, G.R., Herman, A.G. & Bult, H. 2003. Phagocytosis and macrophage activation associated with hemorrhagic microvessels in human atherosclerosis. Arterioscler Thromb Vasc Biol 23, 440-446.
74. Kolb, S., Vranckx, R., Huisse, M.G., Michel, J.B. & Meilhac, O. 2007. The phosphatidylserine receptor mediates phagocytosis by vascular smooth muscle cells. J Pathol 212, 249-259.
75. Kolodgie, F.D., Gold, H.K., Burke, A.P., Fowler, D.R., Kruth, H.S., Weber, D.K., Farb, A., Guerrero, L.J., Hayase, M., Kutys, R., Narula, J., Finn, A.V. & Virmani, R. 2003. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 349, 2316-2325.
76. Kolodgie, F.D., Burke, A.P., Nakazawa, G., Cheng, Q., Xu, X. & Virmani, R. 2007. Free cholesterol in atherosclerotic plaques: where does it come from? Curr Opin Lipidol 18, 500-507.
77. Kou, B., Zhang, J. & Singer, D.R. 2009. Effects of cyclic strain on endothelial cell apoptosis and tubulogenesis are dependent on ROS production via NAD(P)H subunit p22phox. Microvasc Res 77, 125-133.
78. Kovanen, P.T. 2007. Mast cells: multipotent local effector cells in atherothrombosis. Immunol Rev 217, 105-122.
79. Kubo, T., Tanaka, A., Ino, Y., Kitabata, H., Shiono, Y. & Akasaka, T. 2014. Assessment of coronary atherosclerosis using optical coherence tomography. J Atheroscler Thromb 21, 895-903.
80. Kwon, H.M., Sangiorgi, G., Ritman, E.L., McKenna, C., Holmes, D.R., Schwartz, R.S. & Lerman, A. 1998. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Clin Invest 101, 1551-1556.
81. Laine, P., Kaartinen, M., Penttilä, A., Panula, P., Paavonen, T. & Kovanen, P.T. 1999. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation 99, 361-369.
82. van Lammeren, G.W., Pasterkamp, G., de Vries, J.P., Bosch, L., de Haan, J.J., de Kleijn, D.P., Moll, F.L. & Vink, A. 2012. Platelets enter atherosclerotic plaque via intraplaque microvascular leakage and intraplaque hemorrhage: a histopathological study in carotid plaques. Atherosclerosis 222, 355-359.
83. Le Dall, J., Ho-Tin-Noe, B., Louedec, L., Meilhac, O., Roncal, C., Carmeliet, P., Germain, S., Michel, J.B. & Houard, X. 2010. Immaturity of microvessels in haemorrhagic plaques is associated with proteolytic degradation of angiogenic factors. Cardiovasc Res 85, 184-193.
84. Leclercq, A., Houard, X., Philippe, M., Ollivier, V., Sebbag, U., Meilhac, O. & Michel, J.B. 2007. Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment. J Leukoc Biol 82, 1420-1429.
85. Lee, M., Calabresi, L., Chiesa, G., Franceschini, G. & Kovanen, P.T. 2002. Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux. Arterioscler Thromb Vasc Biol 22, 1475-1481.
86. Lees, M., Taylor, D.J. & Woolley, D.E. 1994. Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B. Eur J Biochem 223, 171-177.
87. Levy, A.P. & Blum, S. 2007. Pharmacogenomics in prevention of diabetic cardiovascular disease: utilization of the haptoglobin genotype in determining benefit from vitamin E. Expert Rev Cardiovasc Ther 5, 1105-1111.
88. Levy, A.P., Asleh, R., Blum, S., Levy, N.S., Miller-Lotan, R., Kalet-Litman, S., Anbinder, Y., Lache, O., Nakhoul, F.M., Asaf, R. et al. 2010. Haptoglobin: basic and clinical aspects. Antioxid Redox Signal 12, 293-304.
89. Lin, H.L., Xu, X.S., Lu, H.X., Zhang, L., Li, C.J., Tang, M.X., Sun, H.W., Liu, Y. & Zhang, Y. 2007. Pathological mechanisms and dose dependency of erythrocyte-induced vulnerability of atherosclerotic plaques. J Mol Cell Cardiol 43, 272-280.
90. Lin, H.L., Xu, X.S., Lu, H.X., Li, C.J., Tang, M.X., Sun, H.W. & Zhang, Y. 2008. Pathological mechanisms of erythrocyte-induced vulnerability of atherosclerotic plaques. Med Hypotheses 70, 105-108.
91. Lin, H.L., Zhang, L., Liu, C.X., Xu, X.S., Tang, M.X., Lv, H.X., Li, C.J., Sun, H.W., Zhang, M., Hong, J. & Zhang, Y. 2010. Haemin-enhanced expression of haem oxygenase-1 stabilizes erythrocyte-induced vulnerable atherosclerotic plaques. Br J Pharmacol 160, 1484-1495.
92. Lindstedt, K.A. & Kovanen, P.T. 2004. Mast cells in vulnerable coronary plaques: potential mechanisms linking mast cell activation to plaque erosion and rupture. Curr Opin Lipidol 15, 567-573.
93. Lindstedt, L., Lee, M., Castro, G.R., Fruchart, J.C. & Kovanen, P.T. 1996. Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid. J Clin Invest 97, 2174-2182.
94. Lindstedt, L., Lee, M. & Kovanen, P.T. 2001. Chymase bound to heparin is resistant to its natural inhibitors and capable of proteolyzing high density lipoproteins in aortic intimal fluid. Atherosclerosis 155, 87-97.
95. Liuzzo, G., Goronzy, J.J., Yang, H., Kopecky, S.L., Holmes, D.R., Frye, R.L. & Weyand, C.M. 2000. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 101, 2883-2888.
96. null T lymphocytes and recurrence of acute coronary events. J Am Coll Cardiol 50, 1450-1458.
97. Luan, Z., Chase, A.J. & Newby, A.C. 2003. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages. Arterioscler Thromb Vasc Biol 23, 769-775.
98. Ma, T., Gao, Q., Zhu, F., Guo, C., Wang, Q., Gao, F. & Zhang, L. 2013. Th17 cells and IL-17 are involved in the disruption of vulnerable plaques triggered by short-term combination stimulation in apolipoprotein E-knockout mice. Cell Mol Immunol 10, 338-348.
99. Maher, B.M., Dhonnchu, T.N., Burke, J.P., Soo, A., Wood, A.E. & Watson, R.W. 2009. Statins alter neutrophil migration by modulating cellular rho activity-a potential mechanism for statins-mediated pleotropic effects? J Leukoc Biol 85, 186-193.
100. Massaro, M., Zampolli, A., Scoditti, E., Carluccio, M.A., Storelli, C., Distante, A. & De Caterina, R. 2010. Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability. Cardiovasc Res 86, 311-320.
101. Mayr, M., Sidibe, A. & Zampetaki, A. 2008. The paradox of hypoxic and oxidative stress in atherosclerosis. J Am Coll Cardiol 51, 1266-1267.
102. McCarthy, M.J., Loftus, I.M., Thompson, M.M., Jones, L., London, N.J., Bell, P.R., Naylor, A.R. & Brindle, N.P. 1999. Angiogenesis and the atherosclerotic carotid plaque: an association between symptomatology and plaque morphology. J Vasc Surg 30, 261-268.
103. McFadden, E.P., Chaabane, L., Contard, F., Guerrier, D., Briguet, A., Douek, P. & Soulas, E.C. 2004. In vivo magnetic resonance imaging of large spontaneous aortic aneurysms in old apolipoprotein E-deficient mice. Invest Radiol 39, 585-590.
104. Meyrier, A. 2006. Cholesterol crystal embolism: diagnosis and treatment. Kidney Int 69, 1308-1312.
105. Michel, J.B., Thaunat, O., Houard, X., Meilhac, O., Caligiuri, G. & Nicoletti, A. 2007. Topological determinants and consequences of adventitial responses to arterial wall injury. Arterioscler Thromb Vasc Biol 27, 1259-1268.
106. Michel, J.B., Virmani, R., Arbustini, E. & Pasterkamp, G. 2011. Intraplaque haemorrhages as the trigger of plaque vulnerability. Eur Heart J 32, 1977-1985.
107. Michel, J.B., Delbosc, S., Ho-Tin-Noé, B., Leseche, G., Nicoletti, A., Meilhac, O. & Martin-Ventura, J.L. 2012. From intraplaque haemorrhages to plaque vulnerability: biological consequences of intraplaque haemorrhages. J Cardiovasc Med (Hagerstown) 13, 628-634.
108. Miller, Y. & Shaklai, N. 1994. Oxidative crosslinking of LDL protein induced by hemin: involvement of tyrosines. Biochem Mol Biol Int 34, 1121-1129.
109. Mitroulis, I., Skendros, P. & Ritis, K. 2010. Targeting IL-1beta in disease; the expanding role of NLRP3 inflammasome. Eur J Intern Med 21, 157-163.
110. Montero, J.A. & Ruiz-Moreno, J.M. 2009. Intravitreal inserts of steroids to treat diabetic macular edema. Curr Diabetes Rev 5, 26-32.
111. Moreno, P.R., Purushothaman, K.R., Fuster, V., Echeverri, D., Truszczynska, H., Sharma, S.K., Badimon, J.J. & O'Connor, W.N. 2004. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation 110, 2032-2038.
112. Motovska, Z., Knot, J. & Widimsky, P. 2010. Stent thrombosis-risk assessment and prevention. Cardiovasc Ther 28, e92-e100.
113. Moulton, K.S. 2006. Angiogenesis in atherosclerosis: gathering evidence beyond speculation. Curr Opin Lipidol 17, 548-555.
114. Moulton, K.S., Vakili, K., Zurakowski, D., Soliman, M., Butterfield, C., Sylvin, E., Lo, K.M., Gillies, S., Javaherian, K. & Folkman, J. 2003. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA 100, 4736-4741.
115. Mulligan-Kehoe, M.J. 2010. The vasa vasorum in diseased and nondiseased arteries. Am J Physiol Heart Circ Physiol 298, H295-H305.
116. Nagy, E., Eaton, J.W., Jeney, V., Soares, M.P., Varga, Z., Galajda, Z., Szentmiklósi, J., Méhes, G., Csonka, T., Smith, A., Vercellotti, G.M., Balla, G. & Balla, J. 2010. Red cells, hemoglobin, heme, iron, and atherogenesis. Arterioscler Thromb Vasc Biol 30, 1347-1353.
117. Nakagawa, K., Shibata, A., Saito, T., Sookwong, P., Kato, S., Tsuduki, T., Matsubara, K. & Miyazawa, T. 2011. Phosphatidylcholine hydroperoxide promotes VEGF-induced angiogenesis in endothelial cells and rat aorta ring cultures. Biochim Biophys Acta 1810, 1205-1211.
118. Nakajima, T., Schulte, S., Warrington, K.J., Kopecky, S.L., Frye, R.L., Goronzy, J.J. & Weyand, C.M. 2002. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation 105, 570-575.
119. Nakamura, S., Inami, S., Murai, K., Takano, M., Takano, H., Asai, K., Yasutake, M., Shimizu, W. & Mizuno, K. 2014. Relationship between cholesterol crystals and culprit lesion characteristics in patients with stable coronary artery disease: an optical coherence tomography study. Clin Res Cardiol 103, 1015-1021.
120. Newby, L.K., Ohman, E.M., Christenson, R.H., Moliterno, D.J., Harrington, R.A., White, H.D., Armstrong, P.W., Van De Werf, F., Pfisterer, M., Hasselblad, V., Califf, R.M. & Topol, E.J. 2001. Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy. Circulation 103, 2891-2896.
121. Nishihira, K., Yamashita, A., Imamura, T., Hatakeyama, K., Sato, Y., Nakamura, H., Yodoi, J., Ogawa, H., Kitamura, K. & Asada, Y. 2008. Thioredoxin in coronary culprit lesions: possible relationship to oxidative stress and intraplaque hemorrhage. Atherosclerosis, 201, 360-367.
122. de Nooijer, R., Verkleij, C.J., von der Thüsen, J.H., Jukema, J.W., van der Wall, E.E., van Berkel, T.J., Baker, A.H. & Biessen, E.A. 2006. Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis. Arterioscler Thromb Vasc Biol 26, 340-346.
123. O'Brien, K.D., McDonald, T.O., Chait, A., Allen, M.D. & Alpers, C.E. 1996. Neovascular expression of e-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 93, 672-682.
124. Olson, F.J., Sihlbom, C., Davidsson, P., Hulthe, J., Fagerberg, B. & Bergström, G. 2010. Consistent differences in protein distribution along the longitudinal axis in symptomatic carotid atherosclerotic plaques. Biochem Biophys Res Commun 401, 574-580.
125. Pang, J.H., Jiang, M.J., Chen, Y.L., Wang, F.W., Wang, D.L., Chu, S.H. & Chau, L.Y. 1996. Increased ferritin gene expression in atherosclerotic lesions. J Clin Invest 97, 2204-2212.
126. Pardo, J., Wallich, R., Ebnet, K., Iden, S., Zentgraf, H., Martin, P., Ekiciler, A., Prins, A., Müllbacher, A., Huber, M. & Simon, M.M. 2007. Granzyme B is expressed in mouse mast cells in vivo and in vitro and causes delayed cell death independent of perforin. Cell Death Differ 14, 1768-1779.
127. Patel, R., Janoudi, A., Vedre, A., Aziz, K., Tamhane, U., Rubinstein, J., Abela, O.G., Berger, K. & Abela, G.S. 2011. Plaque rupture and thrombosis are reduced by lowering cholesterol levels and crystallization with ezetimibe and are correlated with fluorodeoxyglucose positron emission tomography. Arterioscler Thromb Vasc Biol 31, 2007-2014.
128. Peppin, G.J. & Weiss, S.J. 1986. Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils. Proc Natl Acad Sci USA 83, 4322-4326.
129. Post, S., Peeters, W., Busser, E., Lamers, D., Sluijter, J.P., Goumans, M.J., de Weger, R.A., Moll, F.L., Doevendans, P.A., Pasterkamp, G. & Vink, A. 2008. Balance between angiopoietin-1 and angiopoietin-2 is in favor of angiopoietin-2 in atherosclerotic plaques with high microvessel density. J Vasc Res 45, 244-250.
130. Potor, L., Bányai, E., Becs, G., Soares, M.P., Balla, G., Balla, J. & Jeney, V. 2013. Atherogenesis may involve the prooxidant and proinflammatory effects of ferryl hemoglobin. Oxid Med Cell Longev 2013, 676425.
131. Pryshchep, S., Sato, K., Goronzy, J.J. & Weyand, C.M. 2006. T cell recognition and killing of vascular smooth muscle cells in acute coronary syndrome. Circ Res 98, 1168-1176.
132. Rajamäki, K., Lappalainen, J., Oörni, K., Välimäki, E., Matikainen, S., Kovanen, P.T. & Eklund, K.K. 2010. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS ONE 5, e11765.
133. Rajavashisth, T.B., Xu, X.P., Jovinge, S., Meisel, S., Xu, X.O., Chai, N.N., Fishbein, M.C., Kaul, S., Cercek, B., Sharifi, B. & Shah, P.K. 1999. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators. Circulation 99, 3103-3109.
134. Rao, V.H., Kansal, V., Stoupa, S. & Agrawal, D.K. 2014. MMP-1 and MMP-9 regulate epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cells. Physiol Rep 2, e00224.
135. Rodríguez, J.A., Nespereira, B., Pérez-Ilzarbe, M., Eguinoa, E. & Páramo, J.A. 2005. Vitamins C and E prevent endothelial VEGF and VEGFR-2 overexpression induced by porcine hypercholesterolemic LDL. Cardiovasc Res 65, 665-673.
136. Schoenhagen, P., Tuzcu, E.M. & Ellis, S.G. 2002. Plaque vulnerability, plaque rupture, and acute coronary syndromes: (multi)-focal manifestation of a systemic disease process. Circulation 106, 760-762.
137. Scolari, F. & Ravani, P. 2010. Atheroembolic renal disease. Lancet 375, 1650-1660.
138. Shah, P.K., Falk, E., Badimon, J.J., Fernandez-Ortiz, A., Mailhac, A., Villareal-Levy, G., Fallon, J.T., Regnstrom, J. & Fuster, V. 1995. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques: potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 92, 1565-1569.
139. Singh, S., Loke, Y.K. & Furberg, C.D. 2007. Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA 298, 1189-1195.
140. Skaletz-Rorowski, A. & Walsh, K. 2003. Statin therapy and angiogenesis. Curr Opin Lipidol 14, 599-603.
141. Sluimer, J.C., Gasc, J.M., van Wanroij, J.L., Kisters, N., Groeneweg, M., Sollewijn Gelpke, M.D., Cleutjens, J.P., van den Akker, L.H., Corvol, P., Wouters, B.G. & Daemen, M.J. 2008. Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. J Am Coll Cardiol, 51, 1258-1265.
142. Sluimer, J., Kolodgie, F., Bijnens, A.P., Maxfield, K., Pacheco, E., Kutys, B., Duimel, H., Frederik, P.M., van Hinsbergh, V.W., Virmani, R. & Daemen, M.J. 2009. Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage. J Am Coll Cardiol 53, 1517-1527.
143. Smith, A., Alam, J., Escriba, P.V. & Morgan, W.T. 1993. Regulation of heme oxygenase and metallothionein gene expression by the heme analogs, cobalt-, and tin-protoporphyrin. J Biol Chem 268, 7365-7371.
144. Sukhova, G.K., Schönbeck, U., Rabkin, E., Schoen, F.J., Poole, A.R., Billinghurst, R.C. & Libby, P. 1999. Evidence for increased collagenolysis by interstitial collagenases-1 and-3 in vulnerable human atheromatous plaques. Circulation 99, 2503-2509.
145. Takaya, N., Yuan, C., Chu, B., Saam, T., Polissar, N.L., Jarvik, G.P., Isaac, C., McDonough, J., Natiello, C., Small, R., Ferguson, M.S. & Hatsukami, T.S. 2005. Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study. Circulation 111, 2768-2775.
146. Tangirala, R.K., Jerome, W.G., Jones, N.L., Small, D.M., Johnson, W.J., Glick, J.M., Mahlberg, F.H. & Rothblat, G.H. 1994. Formation of cholesterol monohydrate crystals in macrophage-derived foam cells. J Lipid Res 35, 93-104.
147. null T cells in patients with coronary artery disease and individuals with risk factors for atherosclerosis. Cell Immunol 281, 11-19.
148. Tester, A.M., Cox, J.H., Connor, A.R., Starr, A.E., Dean, R.A., Puente, X.S., López-Otín, C. & Overall, C.M. 2007. LPS responsiveness and neutrophil chemotaxis in vivo require PMN MMP-8 activity. PLoS ONE 2, e312.
149. Tolosano, E. & Altruda, F. 2002. Hemopexin: structure, function, and regulation. DNA Cell Biol 21, 297-306.
150. Trape, J., Morales, C., Molina, R., Filella, X., Marcos, J.M., Salinas, R. & Franquesa, J. 2006. Vascular endothelial growth factor serum concentrations in hypercholesterolemic patients. Scand J Clin Lab Invest 66, 261-267.
151. Tziakas, D.N., Chalikias, G.K., Stakos, D., Tentes, I.K., Thomaidi, A., Chatzikyriakou, S., Mitrousi, K., Kortsaris, A.X., Kaski, J.C., Boudoulas, H. & Konstantinides, S. 2009. Statin use is associated with a significant reduction in cholesterol content of erythrocyte membranes. A novel pleiotropic effect? Cardiovasc Drugs Ther 23, 471-480.
152. Vaklavas, C., Lenihan, D., Kurzrock, R. & Tsimberidou, A.M. 2010. Anti-vascular endothelial growth factor therapies and cardiovascular toxicity: what are the important clinical markers to target? Oncologist 15, 130-141.
153. Vale, N., Nordmann, A.J., Schwartz, G.G., de Lemos, J., Colivicchi, F., den Hartog, F., Ostadal, P., Macin, S.M., Liem, A.H., Mills, E., Bhatnagar, N., Bucher, H.C. & Briel, M. Statins for acute coronary syndrome. Cochrane Database Syst Rev 2011., CD006870.
154. Van den Steen, P.E., Proost, P., Wuyts, A., Van Damme, J. & Opdenakker, G. 2000. PE1, Proost P, Wuyts A, Van Damme J, Opdenakker G. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 96, 2673-2681.
155. Van Den Steen, P.E., Wuyts, A., Husson, S.J., Proost, P., Van Damme, J. & Opdenakker, G. 2003. Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. Eur J Biochem, 270, 3739-3749.
156. Virmani, R. & Roberts, W.C. 1983. Extravasated erythrocytes, iron, and fibrin in atherosclerotic plaques of coronary arteries in fatal coronary heart disease and their relation to luminal thrombus: frequency and significance in 57 necropsy patients and in 2958 five mm segments of 224 major epicardial coronary arteries. Am Heart J 105, 788-797.
157. Virmani, R., Kolodgie, F.D., Burke, A.P., Finn, A.V., Gold, H.K., Tulenko, T.N., Wrenn, S.P. & Narula, J. 2005. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 25, 2054-2061.
158. van der Wal, A.C., Becker, A.E., van der Loos, C.M. & Das, P.K. 1994. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89, 36-44.
159. Watanabe, M., Sangawa, A., Sasaki, Y., Yamashita, M., Tanaka-Shintani, M., Shintaku, M. & Ishikawa, Y. 2007. Distribution of inflammatory cells in adventitia changed with advancing atherosclerosis of human coronary artery. J Atheroscler Thromb 14, 325-331.
160. Wilson, S.H., Herrmann, J., Lerman, L.O., Holmes, D.R. Jr, Napoli, C., Ritman, E.L. & Lerman, A. 2002. Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering. Circulation 105, 415-418.
161. Yabluchanskiy, A., Ma, Y., Iyer, R.P., Hall, M.E. & Lindsey, M.L. 2013. Matrix metalloproteinase-9: many shades of function in cardiovascular disease. Physiology (Bethesda) 28, 391-403.
162. Yamakawa, K., Hosoi, M., Koyama, H., Tanaka, S., Fukumoto, S., Morii, H. & Nishizawa, Y. 2000. Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells. Biochem Biophys Res Commun 271, 571-574.
163. Yang, J.J., Preston, G.A., Pendergraft, W.F., Segelmark, M., Heeringa, P., Hogan, S.L., Jennette, J.C. & Falk, R.J. 2001. Internalization of proteinase 3 is concomitant with endothelial cell apoptosis and internalization of myeloperoxidase with generation of intracellular oxidants. Am J Pathol 158, 581-592.
164. You, X., Huang, P., Zhang, C., Wang, M., Zhang, Y., Hong, Y., Wei, S., Liu, C., Pu, Z., Zhang, J. & Chen, S. 2014. Relationship between enhanced intensity of contrast enhanced ultrasound and microvessel density of aortic atherosclerostic plaque in rabbit model. PLoS ONE 9, e92445.
165. Yunoki, K., Naruko, T., Komatsu, R., Ehara, S., Shirai, N., Sugioka, K., Nakagawa, M., Kitabayashi, C., Ikura, Y., Itoh, A., Kusano, K., Ohe, T., Haze, K., Becker, A.E. & Ueda, M. 2009. Enhanced expression of haemoglobin scavenger receptor in accumulated macrophages of culprit lesions in acute coronary syndromes. Eur Heart J 30, 1844-1852.
166. null T cells in patients with acute coronary syndromes. Circulation 109, 1230-1235.
167. Zhang, X., Niessner, A., Nakajima, T., Ma-Krupa, W., Kopecky, S.L., Frye, R.L., Goronzy, J.J. & Weyand, C.M. 2006. Interleukin 12 induces T-cell recruitment into the atherosclerotic plaque. Circ Res 98, 524-531.
168. Zhu, X.Y., Rodriguez-Porcel, M., Bentley, M.D., Chade, A.R., Sica, V., Napoli, C., Caplice, N., Ritman, E.L., Lerman, A. & Lerman, L.O. 2004. Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia. Circulation 109, 2109-2115.
169. Zhu, F., Wang, Q., Guo, C., Wang, X., Cao, X., Shi, Y., Gao, F., Ma, C. & Zhang, L. 2011. IL-17 induces apoptosis of vascular endothelial cells: a potential mechanism for human acute coronary syndrome. Clin Immunol 141, 152-160.